[Clinical trial using the beta receptor blockader Visken].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000605:Amino Alcohols / Q000627:therapeutic use*; D000787:Angina Pectoris / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D011433:Propranolol / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use*; D013610:Tachycardia / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D007211:Indoles; D013565:Sympatholytics; D011433:Propranolol
Eine klinische Prüfung des  -Rezeptorenblockers Visken.